Devices - DiabetesontheNet

This site is intended for healthcare professionals only

Devices

Filter:

Conference over coffee: Physical activity, insulin, CGM, EOT2D and the Alphabet strategy

Key messages to take back to our practice from the 2024 Welsh Conference of the PCDS.

Editorial: Updated guidance on prescribing incretin-based therapy, cardiovascular risk reduction and the wider uptake of CGM

Jane Diggle highlights advice on preventing eye damage when initiating new incretin-based therapies.

Editorial: Lipid management, tirzepatide and hybrid closed-loop: What does new NICE guidance recommend?

With a raft of newly published NICE guidance, Jane Diggle discusses the implications for practice in primary care.

At a glance factsheet: Hybrid closed-loop therapy

What are HCL systems and what do we need to know about them in primary care?

How to initiate and support continuous glucose monitoring

An overview of CGM, both real-time and intermittently scanned, for healthcare professionals working within primary care.

Much to celebrate, but challenges are mounting

Su Down celebrates a great innovator, but casts a concerned eye over supply issues.

Case study: Type 1 diabetes diagnosis in a 9-year-old girl with pre-existing hearing loss from congenital causes

Providing equitable care for a child with diabetes and hearing loss: considerations for the diabetes team.

Simplified meal announcement for adolescents using a hybrid closed-loop system

Simplified meal announcements enabled most participants to achieve TIR targets and could be an option for people who struggle with precise carb counting.

Long-term impact of isCGM use: ABCD UK audit

Sustained and significant reductions in HbA1c, hypoglycaemia awareness and diabetes distress observed across all follow-up durations up to 5 years.

Efficacy and safety of hybrid closed-loop systems in children and young people

Hybrid closed-loop systems result in significant improvements in glycaemic control, hypoglycaemia, fear of hypos and sleep scores.

Racial disparities in CGM and pump access in the US

Lower rates of discussion, prescribing and use of CGM and insulin pumps in Black people. Are there lessons for the UK?

Low-dose empagliflozin as an adjunct to hybrid closed-loop therapy

Low-dose empagliflozin increases time in range by ~10% compared with placebo in people using closed-loop therapy.

A challenging year for nursing but with many positives to celebrate in diabetes

Amid the great turmoil and challenges faced by nurses, Su Down looks for the positives in diabetes care in 2022.

Quick guide: Assessing hypoglycaemia awareness

Tools to assess hypoglycaemia unawareness, one of the NICE criteria for CGM use in people with type 2 diabetes.

Type 1 diabetes prevention and screening, hybrid closed-loop systems, principles of good peer support

Stay abreast of the latest news that could impact diabetes nursing.

We got there in the end: A great step forward in type 1 diabetes care

Both technological and biological interventions have hit major milestones and are offering a step change in how we treat type 1 diabetes.

FLASH-UK: Benefits of isCGM in people with high HbA1c

Results demonstrate the effectiveness of intermittently scanned CGM in people with high HbA1c.

CGM-derived metrics are superior to HbA1c when assessing therapeutic efficacy

When evaluating the efficacy of an intervention, mean glucose would be the best metric, followed by TAR, TIR and lastly HbA1c.

Resources

For the latest news and articles

Sign up to all DiabetesontheNet journals

Follow us for all the latest news and updates in diabetes.

Resources

Journals

Useful information

© Copyright Omniamed Communications. All Rights Reserved
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom

;